Drs. Marc Bloomenstein and Doug Devries discuss Neurotrophic Keratitis (NK), highlighting its progression, diagnosis, and treatment strategies.

They emphasize the importance of recognizing early signs, such as reduced blink rate and corneal sensitivity, to prevent further epithelial damage. Treatment options, including the use of amniotic membranes and cenegermin, are explored for their effectiveness in stimulating corneal nerve sensitivity and healing.

To watch the full-length video, enter your information on the right.

To claim credit, log into the TFG Learning Center and take this course.

This activity, COPE Activity Number 128139, is accredited by COPE for continuing education for optometrists.
COPE Course No.: 90672-TD

Release Date: 04-02-2024
Expiration Date: 04-01-2025

Grant Support Statement
This activity is supported by unrestricted educational grants from Alcon, Dompe, Harrow, Horizon Therapeutics, SightSciences, Tarsus Pharmaceuticals, Inc. and Trukera.